Onkos Surgical - About the company
Onkos Surgical is a series C company based in Parsippany Troy Hills (United States), founded in 2015 by Antony Koblish and Patrick Treacy. It operates as a Modular segmental solutions (3D printing) for orthopedic procedures. Onkos Surgical has raised $110M in funding from Canaan and 1315 Capital. The company has 221 active competitors, including 73 funded and 15 that have exited. Its top competitors include companies like ClearPoint Neuro, LensAR and Proprio.
Company Details
Onkos Surgical is focused on developing implants and instruments for musculoskeletal tumor patients. The Guardian Limb Salvage System is designed to provide options for patients when a surgical intervention is required due to cancer or metastatic diseases. The system is indicated for procedures when a radical resection and replacement of the proximal tibia and/or proximal, distal and/or total femur is required. They use 3D technology to develop modular systems patient specific products. Its solutions include the GUARDIAN Limb Salvage System which includes hinges for the femur and tibia for indications during surgical intervention. It has partnered with Vivex Biomedical to provide a portfolio of tissue products to support the needs of musculoskeletal oncologists. The company's uDesign Patient Solutions is a combination of advanced 3D printing technologies, limb restoration technologies, and biologic solutions.
- Website
- onkossurgical.com
Key Metrics
Founded Year
2015
Location
Parsippany Troy Hills, United States
Stage
Series C
Total Funding
$110M in 6 rounds
Latest Funding Round
Ranked
4th among 221 active competitors
Employee Count
104 as on Jul 31, 2026
Similar Companies
Sign up to download Onkos Surgical's company profile
Onkos Surgical's funding and investors
Onkos Surgical has raised a total funding of $110M over 6 rounds. Its first funding round was on Oct 08, 2015. Its latest funding round was a Venture Debt round on Jan 08, 2025 for $*****. 1 investor participated in its latest round. Onkos Surgical has 6 institutional investors.
Here is the list of recent funding rounds of Onkos Surgical:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 08, 2025 | 7463567 | Venture Debt | 6103934 | 9469720 | 7378143 | 7420217 |
May 12, 2023 | 7570805 | Series C | 1203809 | 8134207 | 9949169 | |
Aug 31, 2021 | 9264348 | Series C | 9795430 | 4303071 | 9629824 | 8379041 |
View details of Onkos Surgical's funding rounds and investors
Onkos Surgical's founders and board of directors
Founder? Claim ProfileThe founders of Onkos Surgical are Antony Koblish and Patrick Treacy. Patrick Treacy is the CEO of Onkos Surgical.
Here are the details of Onkos Surgical's key team members:
- Antony Koblish: Co-Founder of Onkos Surgical and founder of 1 other company. They serve on the board of 1 company.Contact Info: 1 email address
- Patrick Treacy: Co-Founder & CEO of Onkos Surgical. Contact Info: 1 email address
View details of Onkos Surgical's Founder profiles and Board Members
Onkos Surgical's employee count trend
Onkos Surgical has 104 employees as of Jul 26. Here is Onkos Surgical's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Onkos Surgical's Competitors and alternates
Top competitors of Onkos Surgical include ClearPoint Neuro, LensAR and Proprio. Here is the list of Top 10 competitors of Onkos Surgical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ClearPoint Neuro 1998, Irvine (United States), Public | Developer of MRI-guided stereotactic system for neurological interventions | $33.7M | 64/100 | |
2nd | LensAR 2004, Orlando (United States), Acquired | Laser Technology with AR feature for cataract surgery | $99M | 64/100 | |
3rd | Proprio 2016, Seattle (United States), Series B | Manufacturer of surgical navigation platforms using artificial intelligence and sensors | $74.2M | 63/100 | |
4th | Onkos Surgical 2015, Parsippany Troy Hills (United States), Series C | Modular segmental solutions (3D printing) for orthopedic procedures | $110M | 63/100 | |
5th | Apella 2021, San Francisco (United States), Series B | Developer of surgical systems for the operating room | $101M | 63/100 | |
6th | Hypervision Surgical 2020, London (United Kingdom), Series A | AI-based tissue analysis software for surgical precision | $31M | 60/100 | |
7th | VitVio 2023, San Francisco (United States), Seed | AI and computer vision platform for surgical operating rooms | $10M | 59/100 | |
8th | Caresyntax 2013, San Francisco (United States), Series C | AI platform that captures and analyzes operating‑room data to optimize surgical workflows and improve patient outcomes | $291M | 58/100 | |
9th | MediView 2017, Cleveland (United States), Series A | Developer of augmented reality visualization systems for medical surgical procedures | $117M | 58/100 | |
10th | Sim and Cure 2014, Montpellier (France), Series A | Designs new generations software to improve neurovascular planning process | $15.3M | 55/100 |
Looking for more details on Onkos Surgical's competitors? Click here to see the top ones
Onkos Surgical's Investments and acquisitions
Onkos Surgical has made no investments or acquisitions yet.
Reports related to Onkos Surgical
Here is the latest report on Onkos Surgical's sector:
News related to Onkos Surgical
Media has covered Onkos Surgical for a total of 3 events in the last 1 year, 3 of them have been about company updates.
•
Onkos Surgical Announces 500th Case Using NanoCept Antibacterial Technology with ELEOS SystemPR Newswire•Jun 29, 2026•Onkos Surgical
•
Onkos Surgical Launches NanoCept Innovation Center for Antibacterial TechnologyOrthopedics•Dec 29, 2025•Onkos Surgical
•
•
•
Horizon Technology Finance Provides $35MM Venture Loan Facility to Onkos SurgicalABL Advisor•Jan 09, 2025•Horizon, Onkos Surgical
•
Onkos Surgical gets $35M loan to commercialize its antibacterial implant.Business Wire•Jan 08, 2025•Onkos Surgical, Horizon
•
Onkos Surgical wins FDA de novo nod for antibacterial-coated orthopedic implantsMassDevice•Apr 09, 2024•Onkos Surgical
•
Onkos Surgical Announces Expanded Capability In Pediatric Musculoskeletal Oncology And Unveils New Manufacturing And Innovation CenterPR Newswire•Jul 19, 2023•Onkos Surgical
•
FDA clears Onkos Surgical's 3D-printed pelvic reconstruction implantsFierce Biotech•Jul 14, 2022•Onkos Surgical
•
Onkos Acquires System to Treat Pediatric Bone Cancer PatientsOrthopedics•Jun 23, 2022•Onkos Surgical, Kalamazoocity
Are you a Founder ?
FAQs about Onkos Surgical
Explore our recently published companies
- Mad Florals - Unfunded company
- Center Moriches Garage Door Repair - Center Moriches based, Unfunded company
- Dog Daze Photo - 1827 founded, Unfunded company
- Buzzkito - Homestead based, Unfunded company
- His N Hers Cuts - Downey based, Unfunded company
- Same Day Pest Control - Box Hill based, Unfunded company